UBS Group
RMTI icon

UBS Group’s Rockwell Medical RMTI Stock Holding History

UBS Group’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$1K – 8767
2015
Q1 		$1K Sell
1
-23
-96% -$26.9K ﹤0.01% 8590
2014
Q4 		$27K Buy
+24
New +$24.6K ﹤0.01% 7228

Other funds holding RMTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group's RMTI Position: Q2 2026 in Review

UBS Group reduced its Rockwell Medical (RMTI) stake by 61% in Q2 2026, selling an estimated $86.2K and leaving 7,001 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7723.

UBS Group first reported a position in RMTI in Q4 2014 and has held it in 47 quarters since. The position peaked at $556K in Q2 2016. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

  • UBS Group held 7,001 shares of Rockwell Medical worth $38.5K as of Q2 2026.
  • UBS Group sold 10,888 Rockwell Medical shares in Q2 2026, an estimated $86.2K.
  • Rockwell Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7723 holding.
  • UBS Group first reported a position in Rockwell Medical in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Rockwell Medical position peaked at $556K in Q2 2016.
  • 37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.